4DMedical
4DX.AX4DMedical Limited Price (4DX.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
327,078,836
(9.0214)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
4DMedical LimitedCurrency: AUD
| YEAR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
252,811.00
+0% |
350,890.00
+39% |
1,925.00
-99% |
789,259.00
+40,900% |
695,001.00
-12% |
1,232,501.00
+77% |
216,978.00
-82% |
1,054,300.00
+386% |
282,181.00
-73% |
3,754,256.00
+1,230% |
|||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 1,613.00 | 28,618.00 | 2,933,391.00 | 3,804,003.00 | 4,421,942.00 | 9,366,469.00 | 91,853.00 | 773,683.00 | 34,146.00 | 236,717.00 | |||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
251,198.00
+0% |
322,272.00
+28% |
-2,931,466.00
-1,010% |
-3,014,744.00
+3% |
-3,726,941.00
+24% |
-8,133,968.00
+118% |
125,125.00
-102% |
280,617.00
+124% |
248,035.00
-12% |
3,517,539.00
+1,318% |
|||||||||
| Gross Profit Ratio | (0.99%) | (0.92%) | (-1,522.84%) | (-3.82%) | (-5.36%) | (-6.60%) | (0.58%) | (0.27%) | (0.88%) | (0.94%) | |||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 0.00 | 0.00 | 2,289,679.00 | 3,523,115.00 | 2,358,017.00 | 4,443,625.00 | 4,036,534.00 | 694,498.00 | |||||||||
| General and Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11,738,154.00 | 19,754,257.00 | 23,153,384.00 | 28,752,212.00 | |||||||||
| Selling, General & Admin... | 288,364.00 | 317,209.00 | 1,747,435.00 | 2,158,816.00 | 3,290,712.00 | 4,304,945.00 | 12,702,802.00 | 21,126,936.00 | 25,111,818.00 | 30,167,144.00 | |||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 964,648.00 | 1,372,679.00 | 1,958,434.00 | 1,414,932.00 | |||||||||
| Depreciation and Amortiz... | 4,288.00 | 15,983.00 | 126,490.00 | 164,234.00 | 103,944.00 | 584,653.00 | 741,481.00 | 1,495,713.00 | 2,565,338.00 | 4,064,790.00 | |||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,590,721.00 | 12,287,862.00 | 13,556,117.00 | 0.00 | |||||||||
| Total Operating Expenses | 390,032.00 | 1,118,469.00 | 1,747,435.00 | 2,158,816.00 | 3,290,712.00 | 7,828,060.00 | 24,463,880.00 | 37,031,191.00 | 45,254,334.00 | 31,483,799.00 | |||||||||
| Cost and Exponses | 391,645.00 | 1,147,087.00 | 4,680,826.00 | 5,962,819.00 | 7,712,654.00 | 17,194,529.00 | 24,555,733.00 | 37,804,874.00 | 45,288,480.00 | 31,720,516.00 | |||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-190,548.00
+0% |
-854,869.00
+349% |
-4,678,900.00
+447% |
-5,173,560.00
+11% |
-7,017,650.00
+36% |
-15,962,030.00
+127% |
-18,777,823.00
+18% |
-36,750,574.00
+96% |
-31,130,074.00
-15% |
-27,966,260.00
-10% |
|||||||||
| Operating Income Ratio | (-0.75%) | (-2.44%) | (-2,430.60%) | (-6.55%) | (-10.10%) | (-12.95%) | (-86.54%) | (-34.86%) | (-110.32%) | (-7.45%) | |||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 196.00 | 70.00 | 3,171.00 | 6,115.00 | 3,698.00 | 57,143.00 | 31,161.00 | 92,603.00 | 607,566.00 | 1,237,280.00 | |||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 15,000.00 | 300,267.00 | 8,018,507.00 | 2,627,400.00 | 179,559.00 | 6,502.00 | 263,960.00 | |||||||||
| Total Other Income/Exp... | 51,519.00 | -801,331.00 | 25,030.00 | 643,786.00 | -123,959.00 | -6,831,310.00 | -7,711,331.00 | -2,348,651.00 | -483,242.00 | -12,429,240.00 | |||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -186,260.00 | -838,886.00 | -4,552,410.00 | -4,350,541.00 | -6,737,401.00 | -15,769,570.00 | -18,036,342.00 | -36,341,485.00 | -33,744,395.00 | -31,856,762.00 | |||||||||
| EBITDA ratio | (-0.74%) | (-2.39%) | (-2,364.89%) | (-6.35%) | (-9.95%) | (-12.48%) | (-83.13%) | (-33.44%) | (-101.23%) | (-8.49%) | |||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -139,029.00 | -796,268.00 | -4,653,870.00 | -4,529,774.00 | -7,141,612.00 | -22,793,340.00 | -21,405,223.00 | -24,549,668.00 | -31,136,576.00 | -40,395,500.00 | |||||||||
| Income Before Tax Ratio | (-0.55%) | (-2.27%) | (-2,417.59%) | (-5.74%) | (-10.28%) | (-18.49%) | (-98.65%) | (-23.29%) | (-110.34%) | (-10.76%) | |||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 0.00 | 0.00 | -679,933.00 | -592,794.00 | -650,607.00 | -817,961.00 | 15,308.00 | 43,208.00 | 323,222.00 | -4,416,828.00 | |||||||||
| Net Income | |||||||||||||||||||
| Net Income | -139,029.00
+0% |
-796,268.00
+473% |
-3,973,937.00
+399% |
-3,936,980.00
-1% |
-6,491,005.00
+65% |
-21,975,379.00
+239% |
-21,420,531.00
-3% |
-24,592,876.00
+15% |
-31,459,798.00
+28% |
-35,978,672.00
+14% |
|||||||||
| Net Income Ratio | (-0.55%) | (-2.27%) | (-2,064.38%) | (-4.99%) | (-9.34%) | (-17.83%) | (-98.72%) | (-23.33%) | (-111.49%) | (-9.58%) | |||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -9.34 | -32.77 | -0.03 | -0.03 | -0.04 | -0.08 | -0.08 | -0.08 | -0.10 | -0.11 | |||||||||
| Diluted EPS | -9.34 | -32.77 | -0.03 | -0.03 | -0.04 | -0.08 | -0.08 | -0.08 | -0.10 | -0.11 | |||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 14,891.00 | 24,296.00 | 151,821,506.00 | 151,821,506.00 | 151,821,506.00 | 264,762,406.00 | 261,419,569.00 | 294,508,186.00 | 300,013,539.00 | 327,078,836.00 | |||||||||
| Diluted Share Outstanding | 14,891.00 | 24,296.00 | 151,821,506.00 | 151,821,506.00 | 151,821,506.00 | 264,762,406.00 | 261,419,569.00 | 294,508,186.00 | 300,013,539.00 | 327,078,836.00 | |||||||||